FINTEC (Formerly AsiaBio) have been moving back into the black from the end of FY17.
A few incubatees have started to grow (NETX 0020) and move out of accumulation phase.
OBV indicates strong bullish divergence - indicating that the operator have been accumulating (both FINTEC and NETX)
A tandem move in the near future is likely. Historical pumps >100%.
0150PA offers a low risk leveraged play which will come into being once price consolidates above 0.16 as the dual conversion option is
(1) - 2x 0150PA into one 0150 share
(2) -1x 0150PA + RM0.08 for one 0150 share
On significant break above 0.18, 0150PA will move in tandem with mother shares, allowing 2x leverage at negigible risk (0150PA expires in 2027 and convertible to mother share at any point)
A few incubatees have started to grow (NETX 0020) and move out of accumulation phase.
OBV indicates strong bullish divergence - indicating that the operator have been accumulating (both FINTEC and NETX)
A tandem move in the near future is likely. Historical pumps >100%.
0150PA offers a low risk leveraged play which will come into being once price consolidates above 0.16 as the dual conversion option is
(1) - 2x 0150PA into one 0150 share
(2) -1x 0150PA + RM0.08 for one 0150 share
On significant break above 0.18, 0150PA will move in tandem with mother shares, allowing 2x leverage at negigible risk (0150PA expires in 2027 and convertible to mother share at any point)